GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Rhoen Klinikum AG (OTCPK:RKAGY) » Definitions » EBIT

Rhoen Klinikum AG (Rhoen Klinikum AG) EBIT : $63 Mil (TTM As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Rhoen Klinikum AG EBIT?

Rhoen Klinikum AG's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2024 was $15 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was $63 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Rhoen Klinikum AG's annualized ROC % for the quarter that ended in Mar. 2024 was 2.57%. Rhoen Klinikum AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 7.15%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Rhoen Klinikum AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 14.66%.


Rhoen Klinikum AG EBIT Historical Data

The historical data trend for Rhoen Klinikum AG's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rhoen Klinikum AG EBIT Chart

Rhoen Klinikum AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 63.58 13.79 34.53 39.97 56.08

Rhoen Klinikum AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.18 8.99 15.77 22.60 15.36

Competitive Comparison of Rhoen Klinikum AG's EBIT

For the Medical Care Facilities subindustry, Rhoen Klinikum AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rhoen Klinikum AG's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Rhoen Klinikum AG's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Rhoen Klinikum AG's EV-to-EBIT falls into.



Rhoen Klinikum AG EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $63 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Rhoen Klinikum AG  (OTCPK:RKAGY) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Rhoen Klinikum AG's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

ROC % (Q: Mar. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Mar. 2024 ))/ count )
=43.292 * ( 1 - 16.41% )/( (1448.965 + 1371.847)/ 2 )
=36.1877828/1410.406
=2.57 %

where

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1930.779 - 97.035 - ( 384.779 - max(0, 365.838 - 860.644+384.779))
=1448.965

Invested Capital(Q: Mar. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1969.097 - 84.013 - ( 575.595 - max(0, 396.591 - 909.828+575.595))
=1371.847

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Rhoen Klinikum AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Mar. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=61.432/( ( (863.795 + max(-54.095, 0)) + (853.725 + max(-62.358, 0)) )/ 2 )
=61.432/( ( 863.795 + 853.725 )/ 2 )
=61.432/858.76
=7.15 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(250.303 + 37.311 + 20.094) - (97.035 + 0 + 264.768)
=-54.095

Working Capital(Q: Mar. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(259.2 + 35.97 + 39.063) - (84.013 + 0 + 312.578)
=-62.358

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Rhoen Klinikum AG's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2024 )
=62.711/427.674
=14.66 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Rhoen Klinikum AG EBIT Related Terms

Thank you for viewing the detailed overview of Rhoen Klinikum AG's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Rhoen Klinikum AG (Rhoen Klinikum AG) Business Description

Traded in Other Exchanges
Address
Salzburger Leite 1, Bad Neustadt a. d. Saale, DEU, 97616
Rhoen Klinikum AG provides medical care focused in five key areas: cardiovascular medicine, neuromedicine, oncology, pulmonary diseases, and orthopedic and trauma surgery. The firm operates in three business areas: acute hospitals, medical care centers, and rehabilitation hospitals. The acute hospitals business contributes to the vast majority of the firm's overall revenue. The majority of patients at the firm's acute hospitals and medical care centers are treated on an outpatient basis. Rhoen Klinikum generates the entirety of its revenue in Germany, with the Bavaria and Hesse regions contributing the largest proportions of revenue.

Rhoen Klinikum AG (Rhoen Klinikum AG) Headlines

From GuruFocus

Better Know a Company - Rhoen Klinikum (XTER:RHK)

By Chandan Dubey Chandan Dubey 04-26-2013